BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 8721678)

  • 1. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D; Solomon E
    Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
    Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
    Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ; Chen LJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
    Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF; Solomon E
    Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
    Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
    Zhang JW; Wang JY; Chen SJ; Chen Z
    J Biosci; 2000 Sep; 25(3):275-84. PubMed ID: 11022230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Dejean A
    Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z; Chen SJ; Wang ZY
    C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.
    Chen Z; Guidez F; Rousselot P; Agadir A; Chen SJ; Wang ZY; Degos L; Zelent A; Waxman S; Chomienne C
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1178-82. PubMed ID: 8302850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation.
    Wells RA; Hummel JL; De Koven A; Zipursky A; Kirby M; Dubé I; Kamel-Reid S
    Leukemia; 1996 Apr; 10(4):735-40. PubMed ID: 8618456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Jansen J; Dejean A
    Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.